本文来自彭博终端，终端用户可运行NSN SZEUI8DWLU6A阅读原文。非终端用户可点击文末 "阅读原文" 预约演示。 彭博行业研究 (Bloomberg Intelligence) 就各公司、行业和市场提供全球投研分析以及交互式 数据。在 环境、社会与治理（ESG） 方面，BI研究立于行业前沿，聚焦热门话题，为您分享 关键洞察。 扫描二维码 立即订阅 彭博ESG双周报 本期主题：ESG债务发行量下滑3% 受关税和企业发债低迷影响 可持续发展债务发行正缩小差距 截至6月发行量下降3% 年初迄今的可持续发展债务发行量为1 . 0 9万亿美元，创下我们于2 0 0 1年开始记录数据以来的 次高上半年发行量。截至6月，绿色债券的发行量领跑，发行规模达3 , 7 7 0亿美元（占ESG债 券总发行量的3 5%），但仍不及其过去两年的上半年表现。社会责任和可持续发展证券类型 的发行量则超过去年同期。吉利美是推动社会责任债券发行量增长的主要动力，而可持续发 展债券则受益于超国家组织的强劲发行。社会责任债券以3 , 6 2 0亿美元的发行量排在第二位 （占比3 3%），紧随其后的是可持续发展债券，发行量为1 , 3 9 ...

Financial Data and Key Metrics Changes - The group's revenue increased by 81.9% year over year to approximately $519 million [43] - Adjusted profit from continuing operations grew significantly to about $178 million [43] - The net loss narrowed to approximately $24.5 million, largely affected by Legend Biotech's performance [43] Business Line Data and Key Metrics Changes - GenScript Life Science Group's revenue grew by 11.3% to about $248 million [45] - ProBio's revenue surged by 511% to around $402 million [43] - Bestzyme's revenue increased by 8.4% to $28.3 million [43] Market Data and Key Metrics Changes - Revenue from industry customers, particularly pharma, increased due to the development of more M&D companies [45] - Revenue from the Americas and European markets grew, thanks to the successful execution of the global market strategy [48] Company Strategy and Development Direction - The company is focused on expanding market penetration for protein, mRNA, and cell and gene engineering [55] - Investments are being made in automation, capacity expansion, and digital transformation to enhance operational efficiency [55] - The company aims to leverage its global footprint to provide speed, reliability, and consistent delivery to customers [78] Management's Comments on Operating Environment and Future Outlook - Management noted that the geopolitical environment remains complex but the company delivered rapid growth [6] - There is confidence in achieving margin improvement through strategic investments and operational efficiencies [94] - The company anticipates a stronger growth trajectory in the second half of the year across all segments [45] Other Important Information - The company achieved significant ESG milestones, including an upgrade to AA in MSCI ESG ratings and inclusion in the FTSE4Good index [10] - The cash position stood at $970 million, supporting global expansion and R&D efforts [9] Q&A Session Summary Question: ProBio's fee for service and COGS trends - Management clarified that excluding the Lenovo collaboration impact, fee for service business achieved double-digit growth [62] Question: Bestzyme's product breakdown and growth expectations - Management indicated that new product launches and expanded sales personnel in key markets are expected to drive growth in the second half [65] Question: Future milestone payments from Lenovo collaboration - Management expects to recognize a milestone payment of $300 million in the second half, with further payments dependent on clinical trial progress [76] Question: Global expansion and long-term revenue contribution - Management emphasized the importance of a robust global footprint for flexibility and resilience, aiming for sustainable growth [78] Question: Tariff impact on profits - Management reported that tariffs had a low impact on profits, under $4 million, due to the nature of the business [85] Question: ProBio's order trends and backlog - Management noted steady growth in orders and a clear recovery in antibody and protein R&D, with a focus on active backlog management [88]

Core Viewpoint - The article discusses the recent financing round of the recycling plastic company "RuiMo Environmental," highlighting its innovative technology and market potential in the context of increasing global plastic pollution and regulatory pressures for sustainable practices [6][7]. Company Overview - "RuiMo Environmental" was established in 2015 as a technology-driven enterprise in the recycling plastic industry, focusing on high-value recycling of polypropylene (PP) and polyethylene (PE) through a full industry chain model of "recycling-reprocessing-application" [6]. - The company utilizes physical recycling methods to achieve "same-level recycling," ensuring that the performance of recycled pellets is close to that of virgin materials, certified by standards such as FDA and EU RoHS [6][8]. Market Context - Approximately 70% of waste plastics are either landfilled or incinerated, with global regulatory frameworks pushing for increased use of recycled materials in packaging, targeting a 30% usage rate by 2030 in various countries [7]. - The global market for recycled plastic products is projected to reach $174.42 billion (approximately 1.26 trillion RMB) by 2030, with China accounting for about 60% of the global recycled plastic industry [7]. Technological Innovations - "RuiMo Environmental" has developed automatic sorting equipment for polyolefin food packaging waste, enhancing sorting efficiency through visual recognition and digital systems [8]. - The company addresses quality and safety issues in recycled materials through advanced cleaning, high-precision sorting, and melting filtration processes, enabling the production of recycled plastics suitable for high-demand applications [8]. Production Capacity and Strategy - The company has achieved an annual production capacity of tens of thousands of tons, primarily serving strict quality-demanding overseas markets [8]. - "RuiMo Environmental" is exploring technology exports and plans to establish branches in Europe and the United States to be closer to customers [8]. Team Expertise - The founding team includes individuals with extensive experience in the petrochemical and recycling industries, contributing to the development of national standards for recycled plastics in China [9]. Investor Insights - Lukas Visser from Ingka Group emphasizes the company's impact on the local recycling market and the goal of addressing global plastic waste issues through this investment [10]. - Pontus Erntell, President of IKEA China, highlights the commitment to sustainable practices and the opportunities presented by the Chinese market for accelerating the transition to a circular economy [11].

Financial Performance - The Group's revenue from continuing operations reached $518.8 million, marking an impressive 81.9% year-over-year increase compared to H1 2024[5,65] - Adjusted net profit from continuing operations soared to $178.0 million, a substantial 509.6% increase compared to the $29.2 million in H1 2024[5,65] - GenScript revenue increased by 11.3% to $247.6 million[65,67] - ProBio experienced significant growth, with revenue reaching $246.9 million, a 511.1% increase[5,65,70] - Bestzyme's revenue grew by 8.4% to $28.3 million[65,73] GenScript Highlights - GenScript served over 42,000 customers in H1 2025, up from 39,000+ in H1 2024[18] - The number of scientific journals citing GenScript increased to over 112,000, compared to 100,000+ in H1 2024[18] - R&D functions account for approximately 10% of the 5700+ employees globally[6] ProBio Highlights - ProBio's cash position is $371.1 million[70] - 20 CDMO projects in H1 2025, with >50% from global customers[42] Bestzyme Highlights - Bestzyme's R&D expenses increased by 62%, from $2.9 million in H1 2024 to $4.7 million in H1 2025[59] - International revenue contribution increased, accounting for 23% of revenue in H1 2025 compared to 21% in H1 2024[73] Guidance - The company revised its revenue growth target for FY 2025 from 10%-15% to 13%-15%[78] - Bestzyme expects 20%-25% revenue growth with Adjusted GPM ~45%[78]

下一步，上交所将通过进一步优化ESG披露标准、推动提高ESG评级水平、丰富绿色金融产品等措施， 助力提升企业ESG表现、共建可持续发展生态。 （文章来源：深圳商报） 截至目前，沪市超过1300家公司单独披露2024年度ESG相关报告，披露率达到57%，创历史新高；沪市 绿色债券累计发行8627亿元，成为全球主要绿色债券市场；可持续发展指数跟踪产品共计90只，规模合 计731.92亿元，基于中证A500等"A系列"指数、上证180指数等使用中证ESG评价的宽基指数产品共157 只，规模合计2528.48亿元。随着ESG内涵和外延不断深化和拓展，沪市ESG投融资得到极大促进，助 力中国资本市场全球竞争力进一步提升。 【深圳商报讯】（记者钟国斌）上交所近日发布沪市20年来ESG实践探索的阶段性进展，选取生物医 药、石油石化、电力设备、公共事业等17个行业的32家绿色发展标杆企业，以"年份切片"的形式，还原 每一年份对应的标杆性案例或重要突破。 ...

Group 1 - The report highlights the rapid growth in the domestic electric vehicle market, with July 2025 witnessing a year-on-year increase of over 26% in production and sales, accounting for 48.7% of total vehicle sales for the month [20][23][25] - The steel industry has achieved a significant reduction in emissions, with a decrease of over 50% compared to 2018, supported by investments exceeding 30 billion yuan in ultra-low emission transformation [20][21] - The report notes that China has secured the top ten positions in the global energy storage cell market, with a year-on-year increase of 106.15% in shipments during the first half of 2025 [20][21] Group 2 - The report discusses the implementation of a loan interest subsidy policy aimed at service industry operators, which is expected to alleviate financial pressure and enhance service capabilities in sectors such as catering, health, and tourism [28][29] - The report emphasizes the importance of digital infrastructure, noting that China has established the world's largest 5G network and the second-largest computing power system, which supports inclusive social development [20][29] - The report outlines the collaborative efforts of 12 departments to strengthen law enforcement and judicial cooperation for ecological protection in the Yangtze River basin, aiming to address cross-regional enforcement challenges [29][30]

Core Viewpoint - The semiconductor sector in the A-share market is experiencing significant growth, with companies like Cambrian (SH688256) seeing substantial stock price increases and the release of their first ESG report highlighting their commitment to environmental, social, and governance standards [1][3]. Group 1: Company Performance - Cambrian's stock price rose by 12.42% to reach 966.8 yuan, with a market capitalization of 386.4 billion yuan as of August 15 [1]. - The company reported a total R&D investment of 1.072 billion yuan in 2024, with R&D expenditure accounting for 91.3% of its total expenses, ranking second in the A-share semiconductor industry [3]. Group 2: ESG Reporting - Cambrian's 2024 ESG report spans 42 pages and covers six key areas: compliance governance, technological innovation, ecological co-construction, talent development, green operations, and community welfare [2]. - This report marks Cambrian's first issuance of an ESG report, transitioning from previous social responsibility reports, and aligns with international standards for enhanced content and disclosure [3][7]. Group 3: Industry Insights - Among the 182 companies in the A-share semiconductor sector, 75 have released ESG reports, resulting in a disclosure rate of 41.2%, with 8 out of the top 10 companies by market capitalization participating [1]. - The report indicates that data and privacy protection are prioritized issues, with no confirmed complaints regarding customer privacy violations reported by Cambrian [4]. Group 4: Regulatory Context - The ESG report's release is influenced by recent regulatory requirements from major exchanges, necessitating companies to adjust their disclosure frameworks to meet domestic and international standards [3][7]. - The focus on greenhouse gas emissions disclosure is increasing, with Cambrian being one of the few companies to report indirect emissions (Scope 2) data, while the need for comprehensive reporting, including Scope 3 emissions, is emphasized for a complete understanding of carbon footprints [6][7].

Core Insights - GenScript Biotech Corporation reported exceptional interim results for H1 2025, achieving consolidated revenue of approximately US$518.8 million, reflecting an 81.9% year-over-year increase, and demonstrating strong operational leverage and margin resilience [2][9] Financial Performance - Gross profit rose 140.1% to US$320.6 million, while adjusted net profit from continuing operations surged 509.6% to US$178 million, indicating rapid growth and superior profitability [2][9] - The Life Science Services and Products segment generated US$247.6 million in revenue, an 11.3% increase year-over-year, with the protein business experiencing a remarkable 52% uplift [4] - The biologics development CDMO services under ProBio reported US$246.9 million in revenue, a 511.1% increase year-over-year, with adjusted gross margin expanding to 73.6% [5][9] Strategic Growth Drivers - The company is committed to deepening R&D investment, expanding production capacity, and accelerating market penetration to deliver sustainable growth and superior value [4] - Bestzyme, the industrial synthetic biology products unit, grew its revenue by 8.4%, driven by market share gains and innovative enzyme portfolio [6] - GenScript's global production and R&D footprint supports over 60% automation penetration, enhancing supply chain resilience and responsiveness [10] ESG Commitment - GenScript has received top-tier ESG ratings, including an MSCI AA rating and inclusion in the FTSE4Good Index Series, reinforcing its commitment to responsible growth [11][12] - The company’s science-based carbon reduction targets are validated by the SBTi, showcasing its alignment with global best practices in sustainability [11] Outlook - The company anticipates continued growth backed by scaling automation, global brand strength, and an expanding pipeline of innovative solutions, positioning itself to sustain biotech leadership [13]

浙江华友钴业股份有限公司 第一章 总则 第一条 为完善浙江华友钴业股份有限公司（以下简称"公司"）法人治理 结构，充分发挥董事会的职能作用，促进董事会有效履行职责，以形成科学、高 效的决策执行体系和激励约束机制，根据《中华人民共和国公司法》《中华人民 共和国证券法》《上市公司治理准则》等法律、法规和规范性文件以及《浙江华 友钴业股份有限公司章程》（以下简称"公司章程"）的规定，特制定本制度。 第二条 本公司董事会下设战略委员会、审计委员会、提名委员会、薪酬与 考核委员会等四个专门委员会。 第三条 各专门委员会行使公司章程和本制度赋予的各项职权，对董事会负 责。 第二章 人员组成 第四条 各专门委员会成员全部由董事组成。 第八条 审计委员会由三名董事组成，成员应当为不在本公司担任高级管理 人员的董事，其中独立董事应当过半数（至少一名应为会计专业人士）；设召集 人一名，由独立董事（会计专业人士）担任。 第九条 提名委员会由三名董事组成，其中独立董事应当过半数；设召集人 一名，由独立董事担任。 第 1 页 共 5 页 第十条 薪酬与考核委员会由三名董事组成，其中独立董事应当过半数；设 召集人一名，由独立董事担任。 ...

Group 1 - The forum emphasized the integration of ESG principles with AI technology to drive industrial innovation and maximize green value [1][2] - ESG is seen as a core engine to activate industrial momentum and achieve sustainable development [1][3] - The collaboration between ESG and AI is crucial for embedding sustainability into the initial stages of innovation [1][2] Group 2 - The supply chain innovation highlighted the importance of liquid cooling technology in enhancing ESG benefits and efficiency in data centers [2][3] - Chinese companies are making significant strides in the global supply chain through advancements in liquid cooling technology, which reduces energy and water consumption [2][3] - The application of liquid cooling technology in high-performance computing is driving ESG progress within the industry [2][3] Group 3 - The construction of a "computing power - electricity - green electricity" collaborative system is essential for addressing challenges in the photovoltaic and new energy vehicle sectors [3][4] - Direct connection policies for green electricity are critical for optimizing energy consumption and reducing costs associated with traditional power grids [3][4] - Web3 technology is enabling market connections for green electricity, facilitating efficient energy distribution and maximizing green value [4] Group 4 - The integration of ESG practices into supply chains and industrial ecosystems is vital for achieving optimal social and economic outcomes [4] - ESG is positioned as a key driver for reducing AI costs and enhancing market returns, contributing to high-quality economic development [4]